Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Joël Coste a Département
de Biostatistique, Hôpital Cochin, Assistance Publique-Hôpitaux de
Paris, Faculté de Médecine Cochin-Port Royal, Université Paris V,
Paris, France, b Service d'Anatomie et Cytologie Pathologiques,
Hopital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris,
France, c Laboratoire de Physiopathologie,
Département de Biologie des Tumeurs, Institut Curie, Paris,
France, d Centre for Health Economics and
Administration Research (CREGAS), INSERM U537-CNRS UPRESA 8052, Le
Kremlin-Bicêtre, France, e Laboratoire Cartier, Paris,
France, f Service d'Anatomie et
Cytologie Pathologiques, Hôpital Foch, Suresnes, France, g Centre
d'Anatomie Pathologique, Besançon, France, h Service d'Anatomie et Cytologie
Pathologiques, Hôpital Cochin, i Service de
Cytopathologie et Cytométrie clinique, Institut Curie, Paris,
France
Correspondence to: coste{at}cochin.univ-paris5.fr
Objectives:
To compare the sensitivity, specificity,
and interobserver reliability of conventional cervical smear tests, monolayer cytology, and human papillomavirus testing for screening for
cervical cancer.
What is already known on this topic
In several countries liquid based monolayer cytology is replacing
conventional smear tests, despite controversy about whether these more
expensive tests perform better What this study adds
Monolayer testing is less reliable and should not replace conventional
cervical smear testing
Design:
Cross sectional study in which the three
techniques were performed simultaneously with a reference standard
(colposcopy and histology).
Setting:
Public university and private practices in France, with complete independence from the suppliers.
Participants:
828 women referred for colposcopy
because of previously detected cytological abnormalities and 1757 women attending for routine smears.
Main outcome measures:
Clinical readings and
optimised interpretation (two blind readings followed, if necessary, by
consensus). Sensitivity, specificity, and weighted
computed for
various thresholds of abnormalities.
Results:
Conventional cervical smear tests were
more often satisfactory (91% v 87%) according to the
Bethesda system, more reliable (weighted
0.70 v 0.57),
and had consistently better sensitivity and specificity than monolayer
cytology. These findings applied to clinical readings and optimised
interpretations, low and high grade lesions, and populations with low
and high incidence of abnormalities. Human papillomavirus testing
associated with monolayer cytology, whether systematic or for atypical
cells of undetermined significance, performed no better than
conventional smear tests.
Conclusions:
Monolayer cytology is less reliable and
more likely to give false positive and false negative results than conventional cervical smear tests for screening for cervical cancer.
New technologies have been developed to improve the detection of
cervical cancer and its precursors and reduce the rate of false
negative results from conventional cervical smear tests
Conventional cervical smear testing is superior in terms of low and
high grade lesions and in populations with a low or a high incidence of
abnormalities
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.